Daily Archives: December 10, 2020
Guideline: ADA 2021 Standards of Medical Care in Diabetes
10 Dec, 2020 | 00:11h | UTCJust published! New ADA 2022 Guideline for the Management of Diabetes
Guideline Homepage: ADA 2021 Standards of Medical Care in Diabetes – American Diabetes Association (free supplement)
See ADA 2021 Guideline topics below:
Introduction: Standards of Medical Care in Diabetes—2021
Summary of Revisions: Standards of Medical Care in Diabetes—2021
- Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2021
- Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021
- Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021
- Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2021
- Glycemic Targets: Standards of Medical Care in Diabetes—2021
- Diabetes Technology: Standards of Medical Care in Diabetes—2021
- Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021
- Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
- Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
- Older Adults: Standards of Medical Care in Diabetes—2021
- Children and Adolescents: Standards of Medical Care in Diabetes—2021
- Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2021
- Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
- Diabetes Advocacy: Standards of Medical Care in Diabetes—2021
Commentary on Twitter
ADA's "Standards of Medical Care in Diabetes—2021" is finally here! Featuring American Diabetes Association's latest clinical practice recommendations, the global standard for diabetes care. #ADASOC2021
? READ NOW (OPEN ACCESS): https://t.co/VyIT2yJnW8 pic.twitter.com/vOM5XXKLoU
— ADA Professional Publications (@ADA_Pubs) December 9, 2020
Global burden of cardiovascular diseases and risk factors, 1990–2019
10 Dec, 2020 | 09:00h | UTCNews Release: JACC: Cardiovascular Disease Burden, Deaths Are Rising Around the World – Institute for Health Metrics and Evaluation
Commentary on Twitter
A new #GBDstudy looks at global trends and the burden of cardiovascular diseases for 13 underlying causes and 9 related risk factors, and what this means for clinical practice and public health policy. Read more in @JACCJournals: https://t.co/7fsHnMKEg7 pic.twitter.com/ySLKICaBcZ
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) December 9, 2020
Systematic Review: Probiotics probably make little or no difference for patients with acute infectious diarrhea
10 Dec, 2020 | 08:53h | UTCProbiotics for treating acute infectious diarrhoea – Cochrane Library
Summary: Do probiotics help to treat acute infectious diarrhoea? – Cochrane Library
Observational study: Seasonal malaria chemoprevention in localities in west and central Africa was associated with a remarkable reduction in morbidity and mortality from the disease
10 Dec, 2020 | 08:54h | UTC
Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death
10 Dec, 2020 | 08:45h | UTCCommentary: Men face ‘almost three times the odds’ of ICU admission for Covid-19, study says – CNN AND Men with COVID-19 three times more likely to need intensive care: study – MedicalXpress
Commentary on Twitter
Men w/ COVID19 are 3 times more likely to need intensive care & are at significantly higher risk of dying from the virus than women. New research analyzed over 3 million confirmed cases from 46 countries and 44 states. 2 links: https://t.co/g9nYKWxzcv
andhttps://t.co/ZOIfSYImWi— delthia ricks ? (@DelthiaRicks) December 9, 2020
Randomized trial: In patients with recurrent, complicated, or persistent painful diverticulitis, sigmoid resection improved quality of life but was associated with a small but significant risk of major complications
10 Dec, 2020 | 08:51h | UTCAuthor Interview: Laparoscopic Sigmoid Resection vs Conservative Treatment in Improving Quality of Life in Diverticulitis
Commentary on Twitter
In this randomized clinical trial, elective laparoscopic sigmoid resection improved quality of life in patients with recurrent, complicated, or persistent painful diverticulitis but carried a 10% risk of major complications. https://t.co/K7yZqmCP5J
— George Ferzli (@drferzli) November 23, 2020
A nationwide study in Denmark showed a higher than expected risk of cardiac events in patients with cancer receiving immune checkpoint inhibitors
10 Dec, 2020 | 08:49h | UTC
UAE says Chinese vaccine 86% effective, offers few details
10 Dec, 2020 | 08:43h | UTCUAE says Chinese vaccine 86% effective, offers few details – Associated Press
See also: China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says – Bloomberg
UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions
10 Dec, 2020 | 08:41h | UTCUK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions – Reuters
See also: UK probes whether COVID-19 vaccine caused allergic reactions – Associated Press AND NHS told not to give Covid vaccine to those with history of allergic reactions – The Guardian
Vast majority of pregnant women with COVID-19 won’t have complications, study finds
10 Dec, 2020 | 08:39h | UTCOriginal study: Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection – JAMA Network Open
How rich countries are ‘hoarding’ the world’s vaccines, in charts
10 Dec, 2020 | 08:40h | UTCHow Rich Countries Are ‘Hoarding’ The World’s Vaccines, In Charts – NPR
See also: How COVID vaccines are being divvied up around the world – Nature AND Rich countries hoarding Covid vaccines, says People’s Vaccine Alliance – BBC AND Amnesty: rich countries have bought too many COVID-19 vaccines – Reuters
“COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset
10 Dec, 2020 | 08:38h | UTCCOVID-19: when are you most infectious? – The Conversation
Original study and commentaries: Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset